T cell factor (interleukin 2) allows in vivo induction of T helper cells against heterologous erythrocytes in athymic (nu/nu) mice

European Journal of Immunology
H StötterH Wagner

Abstract

Mice carrying the nude mutation (nu/nu) lack a functioning thymus and do not contain detectable levels of immunocompetent T cells. We now report that nu/nu mice to have lymphocytes which can be activated in vivo by heterologous erythrocytes and a Lyt-1 T cell-derived factor (interleukin 2) to generate T helper cells. Thus, a lymphokine is described which is able to restore in vivo T helper cell immunocompetence of nu/nu mice. The data may suggest that nu/nu mice contain a low number of T lymphocytes influenced by the cystic remnant of the nu/nu thymus anlage. Alternatively, the data imply that interleukin 2 circumvents the requirement of a thymus during ontogeny of T lymphocytes.

References

Dec 1, 1979·The Journal of Experimental Medicine·J Watson
Jun 1, 1979·The Journal of Experimental Medicine·S GillisK A Smith
Sep 1, 1979·European Journal of Immunology·H PohlitH von Boehmer
Jun 30, 1975·Annals of the New York Academy of Sciences·F Loor, G E Roelants
May 3, 1972·Nature: New Biology·A Schimpl, E Wecker
Aug 1, 1973·The Journal of Experimental Medicine·K Komuro, E A Boyse
Jun 4, 1971·Science·M Hoffmann, R W Dutton
Sep 1, 1967·The Journal of Experimental Medicine·R I Mishell, R W Dutton
Sep 1, 1971·The Journal of Experimental Medicine·H H WortisJ J Owen

❮ Previous
Next ❯

Citations

Jan 1, 1990·Biotherapy·D H Schwartz, T C Merigan
Sep 1, 1986·Veterinary Immunology and Immunopathology·M Miller-Edge, G Splitter
Jan 1, 1985·International Journal of Immunopharmacology·V J Merluzzi, K Last-Barney
Feb 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·S IkeharaR A Good
Jul 1, 1985·The Journal of Experimental Medicine·H KawamuraJ A Berzofsky
Jan 1, 1989·International Journal of Immunopharmacology·J W HaddenE M Hadden
Mar 1, 1983·Immunology Today·T Hunig
Mar 1, 1989·The Annals of Otology, Rhinology, and Laryngology·T P Wustrow, D Kabelitz
Feb 22, 1984·Proceedings of the Royal Society of London. Series B, Containing Papers of a Biological Character·M MalkovskýC Doré
Jan 1, 1982·Immunological Reviews·Y J Rosenberg
Nov 1, 1985·European Journal of Immunology·I J WeilerE Weiler
Dec 15, 1986·International Journal of Cancer. Journal International Du Cancer·A BalsariG Parmiani
Jan 1, 1989·Seminars in Surgical Oncology·A E Chang, S A Rosenberg
Jan 17, 1983·Klinische Wochenschrift·W SolbachH Wagner
Nov 30, 1982·Biochemical and Biophysical Research Communications·S HinumaK Tsukamoto
Jan 1, 1984·Critical Reviews in Oncology/hematology·R V Smalley, R K Oldham
Jan 1, 1989·Medical Oncology and Tumor Pharmacotherapy·J W Hadden, E M Hadden

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.